Brugmann University Hospital
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
114
Active:1
Completed:79
Trial Phases
5 Phases
Early Phase 1:3
Phase 2:7
Phase 3:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials
Not Applicable
48 (73.8%)Phase 2
7 (10.8%)Phase 3
5 (7.7%)Early Phase 1
3 (4.6%)Phase 4
2 (3.1%)Neutrophil Extracellular Traps (NET's) in Prevalent Kidney Stone
Recruiting
- Conditions
- Kidney Stone
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Brugmann University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06412822
- Locations
- 🇧🇪
CHU Brugmann, Brussel, Belgium
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
Not Applicable
Recruiting
- Conditions
- Chronic Renal Failure
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Brugmann University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06347029
- Locations
- 🇧🇪
Brugmann University Hospital, Brussels, Belgium
Better Understanding of Fatigue After STroke
Not Applicable
Not yet recruiting
- Conditions
- Stroke
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Brugmann University Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06292377
- Locations
- 🇧🇪
CHU Brugmann, Brussels, Belgium
🇧🇪UZ Brussel, Brussel, Belgium
Silicone Particles in Breast Implant Capsules
Recruiting
- Conditions
- Breast Implant Leakage
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Brugmann University Hospital
- Target Recruit Count
- 65
- Registration Number
- NCT06257251
- Locations
- 🇧🇪
CHU Brugmann, Brussels, Belgium
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Phase 2
Recruiting
- Conditions
- Severe Alcohol Use Disorder
- Interventions
- Drug: Active placebo (low dose of psilocybin)
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Brugmann University Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT06160232
- Locations
- 🇧🇪
Brugmann University Hospital, Brussel, Belgium
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
No news found